Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.

MLA

Li, Mingchuan, et al. “Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.” Circulation, vol. 138, no. 7, Aug. 2018, pp. 696–711. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.117.030352.

APA

Li, M., Sala, V., De Santis, M. C., Cimino, J., Cappello, P., Pianca, N., Di Bona, A., Margaria, J. P., Martini, M., Lazzarini, E., Pirozzi, F., Rossi, L., Franco, I., Bornbaum, J., Heger, J., Rohrbach, S., Perino, A., Tocchetti, C. G., Lima, B. H. F., … Ghigo, A. (2018). Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth. Circulation, 138(7), 696–711. https://doi.org/10.1161/CIRCULATIONAHA.117.030352

Chicago

Li, Mingchuan, Valentina Sala, Maria Chiara De Santis, James Cimino, Paola Cappello, Nicola Pianca, Anna Di Bona, et al. 2018. “Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.” Circulation 138 (7): 696–711. doi:10.1161/CIRCULATIONAHA.117.030352.